Tempus, a technology company leading the adoption of AI to advance precision medicine, today highlighted results of the ...

Tempus AI managers support employees through collaboration, cross-functional partnership, professional development, mission alignment, and a culture that encourages employees to take ownership while ...

Some butterfly species there are impressively long-lived. They seem to remain young almost forever and show no obvious signs ...

Investors have had a moment to digest what Tempus AI (NASDAQ:TEM) actually delivered when Q1 2026 results landed on May 5.

The Guillotine has four ingredients, and even if I told you three of them—a strange assembly of scotch whisky and mezcal, ...

Tempus AI (TEM) may be building one of healthcare's fastest-growing artificial intelligence (AI) platforms, but the stock hasn’t given investors much to celebrate lately. Shares are down roughly 15% ...

As CEO Georges Kern explains, a great house is built on more than legacy alone. Brand revivals are fascinating to me—they are both a true challenge and profound responsibility. But when done right, ...

Just when it seemed the pocket watch had become little more than a relic of another age, resigned to languish as a clichéd tension-builder when glanced at in Victorian detective dramas, the category ...

Wondering how members of the royal family keep fit? Well, their routines range from yoga, running, and horseback riding to ...

Blackpearl says this challenges a core assumption behind many AI Sales Development Representative (SDR) tools, which are ...

Learn more about whether Recursion Pharmaceuticals, Inc. or Syndax Pharmaceuticals, Inc. is a better investment based on AAII ...